COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 614
[66] Saunders NR, Daneman R, et al. The blood-brain barrier as an
early target in neurodegenerative disease. Trends Neurosci.
2015;38(10):580-592.
[67] Hay JR, Johnson VE, Young AM, Smith DH, Stewart W.
Blood-Brain Barrier Disruption Is an Early Event That May Persist for
Many Years After Traumatic Brain Injury in Humans. J Neuropathol
Exp Neurol. 2015;74(12):1147-1157.
[68] Sandsmark DK, Bashir A, Wellington CL, Diaz-Arrastia R.
Cerebral Microvascular Injury: A Potentially Treatable
Endophenotype of Traumatic Brain Injury-Induced
Neurodegeneration. Neuron. 2019;103(3):367-379.
[69] Montagne A, Zhao Z, Zlokovic BV. Alzheimer's disease: A
matter of blood-brain barrier dysfunction? J Exp Med.
2017;214(11):3151-3169.
[70] Gray MT, Woulfe JM. Striatal blood-brain barrier permeability
in Parkinson's disease. J Cereb Blood Flow Metab.
2015;35(5):747-750.
[71] Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D,
Constantin G. Functional morphology of the blood-brain barrier in
health and disease. Acta Neuropathol. 2018;135(3):311-336.
[72] Sommer A, Winner B, Prots I. The Trojan horse neuroinflammatory impact of T cells in neurodegenerative
diseases. Mol Neurodegener. 2017;12(1):78.
[73] Morris G, Berk M, Galecki P, Maes M. The emerging role of
autoimmunity in myalgic encephalomyelitis/chronic fatigue
syndrome (ME/cfs). Mol Neurobiol. 2014;49(2):741-756.
[74] Maes M, Leunis JC. Normalization of leaky gut in chronic
fatigue syndrome (CFS) is accompanied by a clinical
improvement: effects of age, duration of illness and the
translocation of LPS from gram-negative bacteria. Neuro
Endocrinol Lett. 2008;29(6):902-910.
614
